Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2016-08-22
|
AZD3293 |
Alzheimer's disease |
3 |
AstraZeneca (UK) Eli Lilly (USA - IN) |
Neurodegenerative diseases |
2016-08-17
|
AT132 |
X-linked myotubular myopathy (XLMTM) |
1 |
Audentes Therapeutics (USA - CA) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2016-08-16
|
SFX-01 |
breast cancer |
1-2 |
Evgen Pharma (UK) |
Cancer - Oncology |
2016-08-15
|
LGD-6972 |
type 2 diabetes |
1b |
Ligand Pharmaceuticals (USA - CA) |
Metabolic diseases |
2016-08-15
|
BI 695501 (biosimilar version of Humira® (adalimumab)) |
Crohn's disease |
3 |
Boehringer Ingelheim (Germany) |
Autoimmune diseases - Inflammatory diseases - Digestive diseases |
2016-08-15
|
Praxbind® (idarucizumab) |
specific antidote for Pradaxa® - reversion of the anticoagulant effect of dabigatran due to uncontrolled life-threatening bleeding requiring urgent intervention or a need to undergo an emergency surgery/urgent invasive procedure. |
|
Boehringer Ingelheim (Germany) |
Cardiovascular diseases - Cerebrovascular diseases |
2016-08-11
|
TransCon Growth Hormone |
growth hormone deficiency |
3 |
Ascendis Pharma (Denmark) |
Endocrine diseases - Hormonal diseases |
2016-08-11
|
tazemetostat - EPZ-6438 (E7438) |
mesothelioma characterized by BAP1 loss-of-function |
2 |
Epizyme (USA - MA) |
Cancer - Oncology |
2016-08-11
|
INO-4212 |
Ebola fever |
1 |
Inovio Pharmaceuticals (USA - PA) GeneOne Life Science (South Korea) |
Infectious diseases |
2016-08-11
|
dasiglucagon (ZP4207) |
severe hypoglycemia in insulin dependent diabetic patients |
2 |
Zealand Pharma (Denmark) |
Metabolic diseases |
2016-08-10
|
migalastat |
Fabry disease |
3 |
GSK (UK) Amicus Therapeutics (USA - NJ) |
Rare diseases - Genetic diseases |
2016-08-10
|
MOB-015 (topical formulation of terbinafine) |
onychomycosis |
3 |
Moberg Pharma (Sweden) |
Infectious diseases |
2016-08-10
|
AMV564, |
acute myeloid leukemia (AML) |
1 |
Amphivena Therapeutics (USA - CA) |
Cancer - Oncology |
2016-08-10
|
RST-001 |
retinitis pigmentosa |
1-2 |
RetroSense Therapeutics (USA - MA) |
Rare diseases - Genetic diseases - Ophtalmological diseases |
2016-08-09
|
selumetinib and docetaxel |
KRAS mutation-positive and metastatic non small cell lung cancer |
3 |
AstraZeneca (UK) |
Cancer - Oncology |
2016-08-08
|
Jetrea® (ocriplasmin) |
vitreomacular adhesion including macular hole |
3 |
Thrombogenics (Belgium) |
Ophtalmological diseases |
2016-08-08
|
Permaderm™ (Engineered Skin Substitute - ESS) |
full-thickness (dermal and epidermal layers of skin) life-threatening pediatric severe burns covering a total body surface area (TBSA) of 50% or greater |
|
Amarantus BioScience (USA – CA) |
Dermatological diseases |
2016-08-08
|
PF582 ( biosimilar ranibizumab ) |
age related macular degeneration (AMD) |
1-2 |
Pfenex (USA - CA) |
Ophtalmological diseases |
2016-08-08
|
Px563L |
anthrax |
1a |
Pfenex (USA - CA) |
Infectious diseases |
2016-08-07
|
GBT440 |
sickle cell disease |
preclinical |
Global Blood Therapeutics (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |